Rimer brother leaves Index

Richard Rimer, one of four brothers at European high tech heavyweight Index Ventures, is leaving the firm to pursue his interests in medical technology.

Richard Rimer has left Index Ventures, where he was a partner in the firm’s Geneva office, to launch his own business focused on medical devices or med tech.

Rimer joined Index to work with two of his brothers David and Neil in 2001 from MediService, a start-up he co-founded and built into Europe’s largest mail-order pharmacy. His third brother Danny joined a year later.

Rimer: divergent interests

Bernard Dallé, a partner at Index, said: “Richard’s interests are in med tech and we are not doing a lot of that. Index’s focus is on information technology, the interent and biotech. It is just a divergence of interest.”

Dallé said Rimer was planning to take September off.

At Index, he was focused on investments in the biotech and healthcare infrastructure sectors, serving on the boards of companies including DirectMedica, a medical consultancy, and Addex Pharmaceuticals, a drug discovery company.

In May this year, the Europe- and Israel-focused venture capital firm strengthened its life sciences team with two hires, appointing former Edmond De Rothschild Investment Partners investment director Michèle Ollier as principal and Roman Flack as associate.

The departing Rimer will continue to work closely with Index, the firm said.